Thyroid Cancer Symposium Presentations

What's New in Thyroid Cancer? A Day for Patients and Their Families

June 12, 2010
Rockefeller Research Laboratories Building
430 East 67th Street (between First & York Avenue)
New York, NY

AGENDA

Welcome

Joan Shey, President & Founder, The Light of Life Foundation

Overview, Thyroid Cancer

Introduction to Thyroid Cancer, Increasing Incidence, Diagnosis

R. Michael Tuttle, M.D., Endocrinology Service at Memorial Sloan-Kettering Cancer Center

Ultrasound Evaluation of the Thyroid

Lucy Hann, M.D., Radiology Service at Memorial Sloan-Kettering Cancer Center

Management of Primary Tumor in Thyroid Cancer

Julia Sosa, M.D., Head & Neck Surgery at Yale University Hospital

Management of the Neck in Thyroid Cancer

Ashok Shaha, M.D., FACS, Head & Neck Service at Memorial Sloan-Kettering Cancer Center

Post-Op Endocrine Issues

Managing Calcium and Thyroid Hormone Replacement

Loren W. Greene, M.D., Endocrinology Service at NYU Langone Medical Center

RAI Ablation: What Should I Expect?

Ravinder Grewal, M.D., Nuclear Medicine Service at Memorial Sloan-Kettering Cancer Center

I¹³¹ Treatment: Radiation Safety Issues.

Christopher Horan, Radiation Safety Technician at Memorial Sloan-Kettering Cancer Center

Questions and Answers (1)

Panel of Speakers, R. Michael Tuttle , M.D. Moderator

Molecular Characterization of Thyroid Cancer: Clinical Relevance

James Fagin, M.D., Chief, Endocrinology Service at Memorial Sloan-Kettering Cancer Center

Clinical Trials in Thyroid Cancer

Eric Sherman, M.D., Head and Neck Oncology Service at Memorial Sloan-Kettering Cancer Center

Questions and Answers (2)

Panel of Speakers, R. Michael Tuttle , M.D. Moderator

R. Michael Tuttle

R. Michael Tuttle

R. Michael Tuttle, MD Associate Professor of Medicine Joan and Sanford I. Weill Medical College of Cornell University New York, New York Associate Attending Physician Department of Medicine Memorial Hospital for Cancer and Allied Diseases New York, New York R. Michael Tuttle, MD attended medical school at the University of Louisville, in Louisville, Kentucky. He went on to do his internship and residency in internal medicine at Dwight David Eisenhower Army Medical Center in Augusta, Georgia. This was followed by a two-year fellowship in endocrinology and one-year of post-doctoral training in molecular biology at Madigan Army Medical Center in Tacoma, Washington. After three years as a staff endocrinologist at Madigan Army Medical Center, Dr. Tuttle transferred to Walter Reed Army Medical Center in Washington, DC. At Walter Reed he served as assistant chief of the Thyroid Clinic, and assistant chief of the Department of Clinical Investigations. Upon leaving the Army, Dr. Tuttle joined the endocrine service at Memorial Sloan Kettering Cancer Center in August of 1999. Dr. Tuttle has a unique combination of expertise in the clinical care of thyroid cancer patients and extensive experience in molecular biology. His primary research interests have been in thyroid cancer, and specifically radiation-induced thyroid cancer. His research efforts have taken him from Kwajalein, Atoll in the Marshall Islands, to the Hanford Nuclear Powerplant in Washington State, to regions downwind of Chernobyl, Ukraine. His clinical research has focused on novel approaches to early detection and treatment of advanced thyroid cancer.

Phone: 646-888-2716
Education: MD, University of Louisville School of Medicine
Residencies: Dwight David Eisenhower Army Medical Center
Fellowships: Madigan Army Medical Center
Board Certifications: Endocrinology and Metabolism
Clinical Expertise: Thyroid Cancer
Department & Service: Medicine---Endocrinology Service